This is ReDent’s first product to obtain marketing approval.
Dental equipment start-up ReDent, based in the Maayan Ventures Ltd. (TASE:MAYN) incubator, has obtained CE Mark approval for its self-adjusting file for root canal treatments, allowing the company to market the product in Europe. This is ReDent’s first product to obtain marketing approval. Maayan owns 23% of ReDent.
Maayan Ventures managing director Tsvika Ben-Porat said ReDent would not begin marketing the file immediately, but would wait for the completion of clinical trials and Food and Drug Administration (FDA) approval for marketing in the US. ReDent expects to obtain FDA approval within a few months.
Published by Globes [online], Israel business news - www.globes.co.il - on November 14, 2006
© Copyright of Globes Publisher Itonut (1983) Ltd. 2006